Treatment of Type 1 Renal Tubular Acidosis (RTA)

Pharmacologic Management

Potassium chloride should be used if additional potassium supplementation is needed beyond what potassium citrate provides, and potassium salts other than chloride or citrate should be avoided as they may worsen metabolic alkalosis, with a reasonable target for serum potassium being 3.0 mmol/L 1
Electrolyte supplements should be spread throughout the day to maintain consistent levels, and consideration should be given to potassium-rich foods, with caution regarding their carbohydrate and calorie content 1

Severe hypokalemia in Type 1 RTA can lead to serious complications, including paralysis, rhabdomyolysis, cardiac rhythm abnormalities, and sudden death, and thiazide diuretics should be avoided for hypercalciuria management in patients with RTA 1

The Kidney International journal recommends using gastric acid suppressants with nonselective COX inhibitors to prevent gastrointestinal complications, and switching to H2 blockers or COX-2 selective agents if proton pump inhibitors cause hypomagnesemia 2
The Kidney International journal advises against aiming for complete normalization of plasma potassium, with a target of 3.0 mmol/L being reasonable, and warns against using potassium-sparing diuretics, ACE inhibitors, or angiotensin receptor blockers as routine therapy to avoid precipitating dangerous hyperkalemia 3